Heme metabolism after discontinued hexachlorobenzene administration in rats: possible irreversible changes and biomarker for hexachlorobenzene persistence

• Published in: Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology Vol. 127; no. 2; pp. 165 - 175
• Main Authors: Billi de Catabbi, S.C, Aldonatti, C, San Martin de Viale, L.C
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01-09-2000
• Subjects: Drug persistence; Hexachlorobenzene; Porphyria; Porphyrins; Uroporphyrinogen; Uroporphyrinogen decarboxylase; Porphyria; URO-D, uroporphyrinogen decarboxylase; UROGEN, uroporphyrinogen; Uroporphyrinogen; HCB, hexachlorobenzene; Drug persistence; Hexachlorobenzene; CYP, cytochrome P450; Porphyrins; Uroporphyrinogen decarboxylase
• ISSN: 0742-8413
• DOI: 10.1016/S0742-8413(00)00149-3

The aim of the present study was to determine whether short-term administration of hexachlorobenzene (HCB) (1 g/kg body wt., suspended in water, 5 days/week), could cause and maintain marked porphyria in the absence of the exogenous drug, and whether porphyria parameters can be useful as biomarkers of HCB persistence in rats. Hepatic uroporphyrinogen decarboxylase activity, its inhibitor formation, porphyrin content and composition were studied in Wistar rats treated with the fungicide for 1, 2, 3, or 4 weeks and then withdrawn for a 20-week period. The time course of urinary porphyrin excretion was studied for 7 weeks either by continuous treatment for the entire period, or a 1-week HCB administration. The degree of porphyria achieved by rats after 20 weeks of suspended HCB administration was severe, independent of the length of the treatment, and even higher than that observed in animals analysed immediately at the end of each treatment. Rats treated with HCB for 1 week showed a modest decrease in uroporphyrinogen decarboxylase and low inhibitor formation, and exhibited a greater enzyme inhibition, inhibitor formation, hepatic porphyrin accumulation, and an altered pattern of porphyrin composition in the absence of the exogenous drug. Independent of the treatment, urinary porphyrins rose after a delay of 5 weeks. Substantial amounts of HCB were still found in fat of rats treated with HCB for 1 week, after a withdrawal period of 20 weeks. These results suggest that the high persistence of HCB in tissues acts as a continuous source of the xenobiotic, and stimulus for heme biosynthesis derangement. The alterations induced by HCB within 1 week of treatment could be regarded as an initial trigger for irreversible damage on heme metabolism. Thus, abnormalities in heme biosynthesis can be considered effective markers of HCB persistence in rats or of irreversible HCB-induced damage. Taking into account the delayed and enhanced metabolic effects of HCB, it is advisable that porphyria parameters should be evaluated not only immediately after exposure, but also some time afterwards, especially in susceptible and occupationally-exposed populations.